BOSTON (TheStreet) -- Paulson & Co. founder John Paulson, who earned a record amount last year with the help of gold and bank investments, is now counting on Transocean (RIG - Get Report) and BlackRock (BLK - Get Report) to keep profits rolling.John Paulson gained notoriety for his big bets on gold and bank stocks such as Wells Fargo ( WFC - Get Report), Goldman Sachs ( GS - Get Report) and Citigroup ( C - Get Report), which netted him a personal profit of $5 billion in 2010, the largest one-year gain in investing history.
Teva Pharmaceutical ( TEVA) Company Profile: Teva Pharmaceutical is a global pharmaceutical company that develops, produces and markets generic drugs covering all major treatment categories. Paulson's Investment: The fund's position in Teva had a market value of $232 million at the end of the fourth quarter, as Paulson & Co. picked up nearly 4.5 million shares of the pharmaceutical company.
J. Crew Group ( JCG) Company Profile: J. Crew is an apparel retailer that offers women's, men's and children's apparel and accessories, including wedding and special occasion attire, weekend clothes, swimwear, loungewear, outerwear, shoes, bags, belts, hair accessories and jewelry. J.Crew received a buyout offer of $3 billion from TPG Capital and Leonard Green, and last month Sears ( SHLD) and Urban Outfitters ( URBN) were looking to launch rival bids, according to a Bloomberg report. Paulson's Investment: The fund bought 6 million shares of J. Crew last quarter, equal to a market value of $258 million as of Dec. 31.
King Pharmaceuticals ( KG) Company Profile: King Pharmaceuticals is a pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and animal-health products. Paulson's Investment: The hedge fund nabbed 20 million shares of King Pharmaceuticals last quarter, worth $281 million as of Dec. 31.
Medtronic ( MDT - Get Report) Company Profile: Medtronic provides innovative products and therapies for use by medical professionals to meet the healthcare needs of their patients. Paulson's Investment: The hedge fund bought more than 9.1 million shares of Medtronic in the fourth quarter. The position had a market value of $338.7 million as of Dec. 31.
Transocean ( RIG - Get Report) Company Profile: Transocean is an international provider of offshore contract drilling services for oil and gas wells. Its two reportable segments are: contract drilling services and other operations. Paulson's Investment: The hedge fund's largest new position had a market value of $500 million at the end of the fourth quarter, after Paulson & Co. bought 7.2 million shares of the offshore drilling company. Despite the big purchase, Transocean still doesn't rank in the portfolio's top 10 holdings based on market value, instead coming in at the 14th spot.